Search filters

List of works by Ilkka Liikanen

Adenoviral E4orf3 and E4orf6 proteins, but not E1B55K, increase killing of cancer cells by radiotherapy in vivo

scientific article published on 9 September 2010

Analysis of predictive and prognostic factors in 290 patients treated with oncolytic adenoviruses.

scientific article published on 4 November 2015

Antiviral and antitumor T-cell immunity in patients treated with GM-CSF-coding oncolytic adenovirus

scientific article

Case-control estimation of the impact of oncolytic adenovirus on the survival of patients with refractory solid tumors

scientific article published on 10 November 2014

Chronic Activation of Innate Immunity Correlates With Poor Prognosis in Cancer Patients Treated With Oncolytic Adenovirus

scientific article published on 27 August 2015

Fate of fenestration in children treated with fontan operation

scientific article

Fc-gamma receptor polymorphisms as predictive and prognostic factors in patients receiving oncolytic adenovirus treatment

scientific article published on 21 August 2013

Immunological data from cancer patients treated with Ad5/3-E2F-Δ24-GMCSF suggests utility for tumor immunotherapy ⬇️

scientific article

Induction of Interferon Pathways Mediates In Vivo Resistance to Oncolytic Adenovirus ⬇️

scientific article published on July 26, 2011

Interleukin 8 activity influences the efficacy of adenoviral oncolytic immunotherapy in cancer patients

scientific article published on 5 January 2018

Light to our people: Educational organization and the mobilization of fennomania in the 1870s

Multimodal approach using oncolytic adenovirus, cetuximab, chemotherapy and radiotherapy in HNSCC low passage tumour cell cultures

scientific article published on 16 December 2009

Oncograms Visualize Factors Influencing Long-Term Survival of Cancer Patients Treated with Adenoviral Oncolytic Immunotherapy.

scientific article published on 22 April 2018

Oncolytic Adenovirus Expressing Monoclonal Antibody Trastuzumab for Treatment of HER2-Positive Cancer

scientific article published on 25 July 2016

Oncolytic adenovirus with temozolomide induces autophagy and antitumor immune responses in cancer patients

scientific article published on 02 April 2013

Oncolytic virotherapy for treatment of breast cancer, including triple-negative breast cancer

scientific article published on 27 August 2015

Predictive and Prognostic Clinical Variables in Cancer Patients Treated With Adenoviral Oncolytic Immunotherapy

scientific article published on 4 April 2016

Serotype chimeric oncolytic adenovirus coding for GM-CSF for treatment of sarcoma in rodents and humans

scientific article

Serum HMGB1 is a predictive and prognostic biomarker for oncolytic immunotherapy

scientific article published on March 2015

T-cell subsets in peripheral blood and tumors of patients treated with oncolytic adenoviruses.

scientific article published on 6 February 2015

Targeted chemotherapy for head and neck cancer with a chimeric oncolytic adenovirus coding for bifunctional suicide protein FCU1.

scientific article published on 13 April 2010

Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM-CSF: Results in vitro, in rodents and in humans

scientific article

Verapamil results in increased blood levels of oncolytic adenovirus in treatment of patients with advanced cancer

scientific article published on November 2011

Paulina is supported by:

About Paulina

Help